CRL Relative Valuation
CRL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRL is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y
Competitors Valuation Multiple
The average P/S ratio for CRL's competitors is 3.27, providing a benchmark for relative valuation. Charles River Laboratories International Inc Corp (CRL) exhibits a P/S ratio of 1.49, which is -54.55% above the industry average. Given its robust revenue growth of -1.08%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Charles River Laboratories International Inc (CRL) currently overvalued or undervalued?
What is Charles River Laboratories International Inc (CRL) fair value?
How does CRL's valuation metrics compare to the industry average?
What is the current P/B ratio for Charles River Laboratories International Inc (CRL) as of Apr 27 2025?
What is the current FCF Yield for Charles River Laboratories International Inc (CRL) as of Apr 27 2025?
What is the current Forward P/E ratio for Charles River Laboratories International Inc (CRL) as of Apr 27 2025?